Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04724005
Status:
COMPLETED
Last Update Posted:
2022-09-29
First Post:
2021-01-22
Brief Title:
Project Affinity Excess Cancer Blood Testing
Sponsor:
Entia Ltd
Organization:
Entia Ltd
Study Overview
Official Title:
Project Affinity Excess Cancer Blood Testing Technique
Status:
COMPLETED
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study investigating cancer blood samples on an iterative measurement systme
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None